{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:08:32Z","timestamp":1791374912057,"version":"4.3.1"},"reference-count":45,"publisher":"American Association for Cancer Research (AACR)","issue":"1","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["CA220512"],"award-info":[{"award-number":["CA220512"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["K01OD030513"],"award-info":[{"award-number":["K01OD030513"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"University of California Tobacco-Related Disease Research Program","award":["T29FT0343"],"award-info":[{"award-number":["T29FT0343"]}]},{"name":"University of California Tobacco-Related Disease Research Program","award":["T32IR4672"],"award-info":[{"award-number":["T32IR4672"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Cancer-associated fibroblasts (CAF) generate an extracellular matrix (ECM) which provides a repository for factors that promote pancreatic cancer progression. In this study, we establish that CAF contribution to pancreatic tumor initiation, i.e., stemness, depends on fibronectin (FN) as a scaffold required for assembly of a collagen-containing fibrotic ECM with a critical dependence on the FN-binding integrins, \u03b15\u03b21 and \u03b1v\u03b23. CAF matrix assembly can be prevented by knockdown of FN, integrin \u03b15, or integrin \u03b23 or by a bispecific antibody with dual recognition of \u03b15\u03b21 and \u03b1v\u03b23 that can also destabilize a preexisting matrix. In mice, the ability of CAFs to produce a stiff collagenous matrix and accelerate tumor initiation can be blocked by knockdown of FN or FN-binding integrins or systemic treatment with the \u03b15\u03b21\/\u03b1v\u03b23 bispecific antibody. Together, these results reveal that dual targeting of the FN-binding integrins, \u03b15\u03b21 and \u03b1v\u03b23, can block the ability of CAFs and their matrix to enhance pancreatic cancer stemness and progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Simultaneous targeting of two integrins that function as receptors for FN, a protumor ECM protein, can prevent fibroblasts from supporting the malignant behavior of pancreatic cancer cells.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-24-0491","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T09:45:34Z","timestamp":1736415934000},"page":"195-208","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Targeting Pancreatic Cancer Cell Stemness by Blocking Fibronectin-Binding Integrins on Cancer-Associated Fibroblasts"],"prefix":"10.1158","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3091-1606","authenticated-orcid":false,"given":"Chengsheng","family":"Wu","sequence":"first","affiliation":[{"name":"1Department of Pathology, Moores Cancer Center, Sanford Consortium for Regenerative Medicine at the University of California, San Diego, La Jolla, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8348-6200","authenticated-orcid":false,"given":"Tami","family":"Von Schalscha","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Moores Cancer Center, Sanford Consortium for Regenerative Medicine at the University of California, San Diego, La Jolla, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4405-6962","authenticated-orcid":false,"given":"Diva","family":"Sansanwal","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Moores Cancer Center, Sanford Consortium for Regenerative Medicine at the University of California, San Diego, La Jolla, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0016-8043","authenticated-orcid":false,"given":"Chen","family":"Qian","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Moores Cancer Center, Sanford Consortium for Regenerative Medicine at the University of California, San Diego, La Jolla, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8724-6171","authenticated-orcid":false,"given":"Qinlin","family":"Jiang","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Moores Cancer Center, Sanford Consortium for Regenerative Medicine at the University of California, San Diego, La Jolla, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7488-369X","authenticated-orcid":false,"given":"Ryan M.","family":"Shepard","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Moores Cancer Center, Sanford Consortium for Regenerative Medicine at the University of California, San Diego, La Jolla, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7144-3122","authenticated-orcid":false,"given":"Hiromi I.","family":"Wettersten","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Moores Cancer Center, Sanford Consortium for Regenerative Medicine at the University of California, San Diego, La Jolla, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6344-9651","authenticated-orcid":false,"given":"Stephen J.","family":"McCormack","sequence":"additional","affiliation":[{"name":"2Alpha Beta Therapeutics, Inc., Claremont, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3137-4239","authenticated-orcid":false,"given":"Sara M.","family":"Weis","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Moores Cancer Center, Sanford Consortium for Regenerative Medicine at the University of California, San Diego, La Jolla, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7193-8595","authenticated-orcid":false,"given":"David A.","family":"Cheresh","sequence":"additional","affiliation":[{"name":"1Department of Pathology, Moores Cancer Center, Sanford Consortium for Regenerative Medicine at the University of California, San Diego, La Jolla, California."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"key":"2025051308525066200_bib1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","article-title":"The tumour microenvironment in pancreatic cancer \u2013 clinical challenges and opportunities","volume":"17","author":"Ho","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"2025051308525066200_bib2","doi-asserted-by":"crossref","first-page":"612271","DOI":"10.3389\/fimmu.2021.612271","article-title":"Stroma involvement in pancreatic ductal adenocarcinoma: an overview focusing on extracellular matrix proteins","volume":"12","author":"Liot","year":"2021","journal-title":"Front Immunol"},{"key":"2025051308525066200_bib3","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s10555-021-09988-w","article-title":"The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions","volume":"40","author":"Herting","year":"2021","journal-title":"Cancer Metastasis Rev"},{"key":"2025051308525066200_bib4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.cell.2009.10.027","article-title":"Matrix crosslinking forces tumor progression by enhancing integrin signaling","volume":"139","author":"Levental","year":"2009","journal-title":"Cell"},{"key":"2025051308525066200_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jso.24643","article-title":"The pancreatic cancer microenvironment: a true double agent","volume":"116","author":"Melstrom","year":"2017","journal-title":"J Surg Oncol"},{"key":"2025051308525066200_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"2025051308525066200_bib7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.18632\/oncotarget.28385","article-title":"Cancer-associated fibroblasts: challenges and opportunities","volume":"14","author":"Tavana","year":"2023","journal-title":"Oncotarget"},{"key":"2025051308525066200_bib8","doi-asserted-by":"crossref","first-page":"108231","DOI":"10.1016\/j.pharmthera.2022.108231","article-title":"Targeting cancer-associated fibroblasts: challenges, opportunities and future directions","volume":"240","author":"Jenkins","year":"2022","journal-title":"Pharmacol Ther"},{"key":"2025051308525066200_bib9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.canlet.2015.12.027","article-title":"Matrix control of pancreatic cancer: new insights into fibronectin signaling","volume":"381","author":"Topalovski","year":"2016","journal-title":"Cancer Lett"},{"key":"2025051308525066200_bib10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1146\/annurev-cellbio-100109-104020","article-title":"Assembly of fibronectin extracellular matrix","volume":"26","author":"Singh","year":"2010","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2025051308525066200_bib11","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.3390\/cells10092443","article-title":"Fibronectin: molecular structure, fibrillar structure and mechanochemical signaling","volume":"10","author":"Dalton","year":"2021","journal-title":"Cells"},{"key":"2025051308525066200_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.addr.2018.01.020","article-title":"Integrins in wound healing, fibrosis and tumor stroma: high potential targets for therapeutics and drug delivery","volume":"129","author":"Schnittert","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"2025051308525066200_bib13","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1172\/JCI118227","article-title":"Anti-integrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin","volume":"96","author":"Brooks","year":"1995","journal-title":"J Clin Invest"},{"key":"2025051308525066200_bib14","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1083\/jcb.111.6.2795","article-title":"The vitronectin receptor alpha v beta 3 binds fibronectin and acts in concert with alpha 5 beta 1 in promoting cellular attachment and spreading on fibronectin","volume":"111","author":"Charo","year":"1990","journal-title":"J Cell Biol"},{"key":"2025051308525066200_bib15","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/j.biomaterials.2010.11.057","article-title":"Role of material-driven fibronectin fibrillogenesis in cell differentiation","volume":"32","author":"Salmer\u00f3n-S\u00e1nchez","year":"2011","journal-title":"Biomaterials"},{"key":"2025051308525066200_bib16","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1083\/jcb.200205014","article-title":"The fibronectin-binding integrins alpha5beta1 and alphavbeta3 differentially modulate RhoA-GTP loading, organization of cell matrix adhesions, and fibronectin fibrillogenesis","volume":"159","author":"Danen","year":"2002","journal-title":"J Cell Biol"},{"key":"2025051308525066200_bib17","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0955-0674(99)00017-4","article-title":"Fibronectin fibrillogenesis: a paradigm for extracellular matrix assembly","volume":"11","author":"Schwarzbauer","year":"1999","journal-title":"Curr Opin Cell Biol"},{"key":"2025051308525066200_bib18","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.tcb.2023.08.001","article-title":"Tumor-initiating cells establish a niche to overcome isolation stress","volume":"34","author":"Wu","year":"2024","journal-title":"Trends Cell Biol"},{"key":"2025051308525066200_bib19","doi-asserted-by":"crossref","first-page":"jcs261483","DOI":"10.1242\/jcs.261483","article-title":"Upregulation of fibronectin and its integrin receptors \u2013 an adaptation to isolation stress that facilitates tumor initiation","volume":"136","author":"Wu","year":"2023","journal-title":"J Cell Sci"},{"key":"2025051308525066200_bib20","doi-asserted-by":"crossref","first-page":"100095","DOI":"10.1016\/j.adcanc.2023.100095","article-title":"Identification and clinical implications of circulating cancer associated fibroblasts in lung cancer patients","volume":"7","author":"Mirza","year":"2023","journal-title":"Adv Cancer Biol\u2013Metastasis"},{"key":"2025051308525066200_bib21","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.18632\/oncotarget.27510","article-title":"Cancer associated fibroblasts confer shear resistance to circulating tumor cells during prostate cancer metastatic progression","volume":"11","author":"Ortiz-Otero","year":"2020","journal-title":"Oncotarget"},{"key":"2025051308525066200_bib22","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1158\/0008-5472.CAN-15-1633","article-title":"Identification of cancer-associated fibroblasts in circulating blood from patients with metastatic breast cancer","volume":"75","author":"Ao","year":"2015","journal-title":"Cancer Res"},{"key":"2025051308525066200_bib23","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/s41467-021-21858-1","article-title":"Tumor-penetrating therapy for \u03b25 integrin-rich pancreas cancer","volume":"12","author":"Hurtado de Mendoza","year":"2021","journal-title":"Nat Commun"},{"key":"2025051308525066200_bib24","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1128\/jb.176.9.2577-2586.1994","article-title":"Characterization of the 16S rRNA genes from Mycoplasma sp. strain F38 and development of an identification system based on PCR","volume":"176","author":"Bascu\u00f1ana","year":"1994","journal-title":"J Bacteriol"},{"key":"2025051308525066200_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/bs.mcb.2017.08.007","article-title":"Cell-derived decellularized extracellular matrices","volume":"143","author":"Harris","year":"2018","journal-title":"Methods Cell Biol"},{"key":"2025051308525066200_bib26","doi-asserted-by":"crossref","first-page":"eaax2770","DOI":"10.1126\/sciadv.aax2770","article-title":"ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer","volume":"5","author":"Kuninty","year":"2019","journal-title":"Sci Adv"},{"key":"2025051308525066200_bib27","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2967\/jnumed.119.233122","article-title":"Theranostics targeting fibroblast activation protein in the tumor stroma: 64Cu- and 225Ac-labeled FAPI-04 in pancreatic cancer xenograft mouse models","volume":"61","author":"Watabe","year":"2020","journal-title":"J Nucl Med"},{"key":"2025051308525066200_bib28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/MPA.0000000000000087","article-title":"PANC-1 pancreatic cancer cell growth inhibited by cucurmosin alone and in combination with an epidermal growth factor receptor-targeted drug","volume":"43","author":"Wang","year":"2014","journal-title":"Pancreas"},{"key":"2025051308525066200_bib29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ncb2953","article-title":"An integrin \u03b23-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition","volume":"16","author":"Seguin","year":"2014","journal-title":"Nat Cell Biol"},{"key":"2025051308525066200_bib30","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"2025051308525066200_bib31","first-page":"2625","article-title":"Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer","volume":"4","author":"Gasparini","year":"1998","journal-title":"Clin Cancer Res"},{"key":"2025051308525066200_bib32","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1021\/acs.molpharmaceut.0c01182","article-title":"Targeting interstitial myofibroblast-expressed integrin \u03b1v\u03b23 alleviates renal fibrosis","volume":"18","author":"Zhou","year":"2021","journal-title":"Mol Pharm"},{"key":"2025051308525066200_bib33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1067-1927.2004.12402.x","article-title":"AlphaV integrins play an important role in myofibroblast differentiation","volume":"12","author":"Lygoe","year":"2004","journal-title":"Wound Repair Regen"},{"key":"2025051308525066200_bib34","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1042\/BJ20141047","article-title":"Disruption of integrin-fibronectin complexes by allosteric but not ligand-mimetic inhibitors","volume":"464","author":"Mould","year":"2014","journal-title":"Biochem J"},{"key":"2025051308525066200_bib35","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.molmed.2020.08.005","article-title":"Blocking CTGF-mediated tumor-stroma interplay in pancreatic cancer","volume":"26","author":"Shen","year":"2020","journal-title":"Trends Mol Med"},{"key":"2025051308525066200_bib36","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1158\/1535-7163.MCT-05-0516","article-title":"Connective tissue growth factor-specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer","volume":"5","author":"Aikawa","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"2025051308525066200_bib37","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1158\/1078-0432.CCR-18-3669","article-title":"Harmonic motion imaging of pancreatic tumor stiffness indicates disease state and treatment response","volume":"26","author":"Payen","year":"2020","journal-title":"Clin Cancer Res"},{"key":"2025051308525066200_bib38","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.3390\/jcm10122711","article-title":"Pancreatic ductal adenocarcinoma: relating biomechanics and prognosis","volume":"10","author":"MacCurtain","year":"2021","journal-title":"J Clin Med"},{"key":"2025051308525066200_bib39","first-page":"3055","article-title":"Cancer-associated fibroblast regulation of tumor neo-angiogenesis as a therapeutic target in cancer","volume":"17","author":"Wang","year":"2019","journal-title":"Oncol Lett"},{"key":"2025051308525066200_bib40","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1177\/1947601911423940","article-title":"The role of stromal myofibroblast and extracellular matrix in tumor angiogenesis","volume":"2","author":"Vong","year":"2011","journal-title":"Genes Cancer"},{"key":"2025051308525066200_bib41","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov"},{"key":"2025051308525066200_bib42","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","article-title":"Cancer-associated fibroblasts: from basic science to anticancer therapy","volume":"55","author":"Yang","year":"2023","journal-title":"Exp Mol Med"},{"key":"2025051308525066200_bib43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jconrel.2023.06.008","article-title":"Fibronectin-targeted FUD and PEGylated FUD peptides for fibrotic diseases","volume":"360","author":"Lee","year":"2023","journal-title":"J Control Release"},{"key":"2025051308525066200_bib44","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1083\/jcb.201702033","article-title":"Cancer-associated fibroblasts lead tumor invasion through integrin-\u03b23-dependent fibronectin assembly","volume":"216","author":"Attieh","year":"2017","journal-title":"J Cell Biol"},{"key":"2025051308525066200_bib45","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.semcancer.2019.08.004","article-title":"Cancer-associated fibroblasts in desmoplastic tumors: emerging role of integrins","volume":"62","author":"Zeltz","year":"2020","journal-title":"Semin Cancer Biol"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-24-0491\/3531593\/crc-24-0491.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/1\/195\/3538455\/crc-24-0491.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/1\/195\/3538455\/crc-24-0491.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T08:53:14Z","timestamp":1747126394000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/5\/1\/195\/751366\/Targeting-Pancreatic-Cancer-Cell-Stemness-by"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-24-0491","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.29050534","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050522","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050546","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050528","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28322507","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28322519","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28322525","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28322537","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28322549","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28322543","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28322513","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28322531","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050540","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050543","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050531","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050537","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.29050525","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28322504","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28322516","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28322528","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28322510","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28322522","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28322534","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.28322540","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.7652432","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]}}}